
Sign up to save your podcasts
Or


In this episode, Dr. Aidan Hollis describes the Health Impact Fund proposal, a revolutionary alternative to the typical pharmaceutical business model in which pharmaceutical companies are given incentive to produce essential medicine that would be sold at nominal cost to individuals who require it.
To learn more about the Health Impact Fund, visit: https://healthimpactfund.org/en/
By teamghpodcastIn this episode, Dr. Aidan Hollis describes the Health Impact Fund proposal, a revolutionary alternative to the typical pharmaceutical business model in which pharmaceutical companies are given incentive to produce essential medicine that would be sold at nominal cost to individuals who require it.
To learn more about the Health Impact Fund, visit: https://healthimpactfund.org/en/